The Oatmeal Bite

The Oatmeal Bite

Lung Cancer Screening Gap in HIV Patients

Eligibility nearly tripled. Fewer than 3 in 10 eligible patients ever got a scan. Here is the framework that actually closes the gap.

Jonathan Govette, CEO/Oatmeal's avatar
Jonathan Govette, CEO/Oatmeal
Oct 05, 2026
∙ Paid

Lung cancer is now the leading cause of cancer death among people living with HIV in the United States.

Read that again.

Not AIDS-defining illnesses. Not opportunistic infections. Lung cancer. A disease with a proven, covered, widely recommended early-detection tool. A disease where screening reduces mortality by approximately 20%. A disease that, if caught early, is survivable.

And yet a new study published in the International Journal of STD & AIDS — covered by The American Journal of Managed Care in October 2026 — found that fewer than 3 in 10 eligible patients living with HIV ever received a low-dose CT scan during a six-year study window.

That is not a guideline failure. The guidelines improved substantially in 2021.

That is not a coverage failure. Low-dose CT screening is covered for qualifying patients.

That is not a contact failure. These patients were already engaged in care, regularly seeing providers for antiretroviral therapy management.

That is an execution failure. And executio…

User's avatar

Continue reading this post for free, courtesy of Jonathan Govette, CEO/Oatmeal.

Or purchase a paid subscription.
© 2026 Jonathan Govette · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.